Systematic review on rocuronium continuous infusion for deep neuromuscular blockade.
Rocuronium is a muscle relaxant with increased use interest due to the binding relation with the reversal agent sugammadex. The purpose of this review entails the investigation of its use for the maintenance of deep neuromuscular block (NMB) via continuous infusion. Based on PRISMA systematic search guidelines, databases included PubMed, ISI Web of Science, Cochrane Library and google scholar. This comprehensive search addresses surgical patients under deep muscle relaxation via continuous rocuronium infusion. Main indicators were the rocuronium administration, NMB monitoring approaches and effects in order to maintain the deep level of relaxation, as well as reversal time after standard dose of sugammadex. Despite the variance in approaches found in the literature, findings show the overall maintenance of deep NMB requires approximately 0.758 mg.kg-1h-1 of rocuronium (according to the PTC target of 0-10, 0-5 and 1-2, mean estimates are 0.445, 0.65 and 0.833 mg.kg-1h-1 respectively), suggesting that a lower range and smaller maximum of PTC response require higher amount of rocuronium for its maintenance. Standard dose of sugammadex (4 mg/kg), administered at the end of the surgery take longer [2.85 (1.17) min] than when administered after moderate NMB recovery [1.68 (0.47) min]. Continuous infusion for deep NMB presents inherent advantages in terms of maintenance and stability of the muscle relaxation. For that purpose, monitoring and rocuronium administration approaches are fundamental and intrinsically connected. Additional efforts should be placed in further studies to better understand the variability and methodological parameters for an improved maintenance of deep NMB.